PSA-PJ(PSA-PJ)
PSA-PJ
Q3 2026 EPS Estimate
$2.54
Jul 29, 2026
Revenue Estimate
$1.23B
FY2026E EPS$10.20
FY2027E EPS$9.88
Analyst Sentiment
Wall St. Consensus
Hold22 analysts·High coverage
57
Score
9 Buy (41%)10 Hold (45%)3 Sell (14%)
Rating Breakdown
Strong Buy
00%
Buy
941%
Hold
1045%
Sell
314%
Strong Sell
00%
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
No analyst price targets available for PSA-PJ
Analyst coverage may not be available for this symbol
Earnings & Revenue Estimates
Forward Growth Estimates (YoY)
FY2027
Rev+7.60%
EPS-3.09%
FY2028
Rev+4.57%
EPS+6.00%
FY2029
Rev+10.24%
EPS+1.53%
Raw consensus estimates (low / average / high) from covering analysts.
Annual
| Metric | FY2026E | FY2027E | FY2028E | FY2029E | FY2030E |
|---|---|---|---|---|---|
| Revenue Avg | $5.04B | $5.43B | $5.67B | $6.25B | $7.34B |
| Low | $4.91B | $5.17B | $5.46B | $6.02B | $7.06B |
| High | $5.16B | $5.81B | $5.94B | $6.55B | $7.68B |
| EBITDA Avg | $4.01B | $4.31B | $4.51B | $4.97B | $5.83B |
| Low | $3.90B | $4.11B | $4.34B | $4.78B | $5.61B |
| High | $4.10B | $4.61B | $4.72B | $5.20B | $6.10B |
| EBIT Avg | $3.10B | $3.33B | $3.48B | $3.84B | $4.50B |
| Low | $3.01B | $3.17B | $3.35B | $3.70B | $4.34B |
| High | $3.16B | $3.57B | $3.65B | $4.02B | $4.72B |
| Net Income Avg | $1.79B | $1.74B | $1.84B | $1.87B | $1.92B |
| Low | $1.71B | $1.65B | $1.75B | $1.78B | $1.82B |
| High | $1.90B | $1.84B | $1.96B | $1.99B | $2.03B |
| EPS Avg | $10.20 | $9.88 | $10.48 | $10.63 | $10.89 |
| Low | $9.70 | $9.40 | $9.97 | $10.12 | $10.36 |
| High | $10.82 | $10.49 | $11.12 | $11.29 | $11.56 |
| Analysts (Rev / EPS) | 6 / 1 | 6 / 1 | 2 / 1 | 5 / 1 | 3 / 1 |
Quarterly
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 | Q1 2028 | Q2 2028 |
|---|---|---|---|---|---|---|---|---|
| Revenue Avg | $1.29B | $1.32B | $1.34B | $1.40B | $1.44B | $1.44B | $1.61B | $1.63B |
| Low | $1.25B | $1.28B | $1.30B | $1.36B | $1.40B | $1.40B | $1.56B | $1.58B |
| High | $1.33B | $1.37B | $1.39B | $1.46B | $1.49B | $1.50B | $1.67B | $1.69B |
| EBITDA Avg | $1.02B | $1.05B | $1.06B | $1.12B | $1.14B | $1.15B | $1.28B | $1.29B |
| Low | $992M | $1.02B | $1.03B | $1.08B | $1.11B | $1.11B | $1.24B | $1.26B |
| High | $1.06B | $1.09B | $1.10B | $1.16B | $1.19B | $1.19B | $1.33B | $1.34B |
| EBIT Avg | $789M | $808M | $820M | $862M | $883M | $886M | $986M | $1000M |
| Low | $766M | $785M | $797M | $838M | $858M | $861M | $958M | $971M |
| High | $819M | $839M | $852M | $895M | $916M | $920M | $1.02B | $1.04B |
| Net Income Avg | $470M | $410M | $401M | $429M | $435M | $435M | $486M | $509M |
| Low | $452M | $395M | $386M | $414M | $419M | $419M | $468M | $490M |
| High | $493M | $430M | $421M | $451M | $457M | $457M | $510M | $534M |
| EPS Avg | $2.67 | $2.33 | $2.28 | $2.44 | $2.47 | $2.47 | $2.76 | $2.89 |
| Low | $2.57 | $2.24 | $2.20 | $2.35 | $2.38 | $2.38 | $2.66 | $2.79 |
| High | $2.80 | $2.45 | $2.39 | $2.56 | $2.60 | $2.60 | $2.90 | $3.04 |
| Analysts (Rev / EPS) | 5 / 1 | 2 / 1 | 2 / 1 | 2 / 1 | 2 / 1 | 2 / 1 | 1 / 1 | 1 / 1 |
Earnings Surprises
Recent Analyst Actions
No recent analyst actions